Vipul Organics reports strong revenue growth as new product lines drive expansion.
Vipul Organics Limited reported a 56.12 per cent year-on-year increase in standalone revenue to Rs 619.24 million in Q2 FY27, compared with Rs 396.64 million in the corresponding quarter of the previous financial year. The speciality chemicals manufacturer recorded higher revenue and profitability, supported by strategic optimisation initiatives and the introduction of new product lines.
Profit before tax (PBT) increased 19.23 per cent year-on-year to Rs 28.49 million from Rs 23.89 million, while profit after tax (PAT) rose 22.20 per cent to Rs 22.16 million from Rs 18.13 million.
On a sequential basis, revenue increased 18.69 per cent from Rs 521.75 million in Q1 FY27. However, PBT declined 17.34 per cent, while PAT fell 12.29 per cent, reflecting temporary cost pressures associated with the company’s ongoing capacity expansion.
For the half-year ended September 30, 2026, standalone revenue increased 47.51 per cent to Rs 1.14 billion from Rs 773.52 million in H1 FY26. PBT grew 56.94 per cent to Rs 62.95 million, while PAT rose 53.85 per cent to Rs 47.42 million.
The company’s consolidated revenue for Q2 FY27 stood at Rs 619.24 million, while consolidated PBT and PAT were Rs 28.43 million and Rs 22.10 million, respectively.
Vipul Organics attributed its revenue growth to strategic operational improvements and the introduction of new products over the past two years. The company’s Sayakha manufacturing facility operated for approximately 40 days during the quarter as production was gradually scaled up.
The initial operational phase resulted in a temporary mismatch between expenses and revenue, affecting profitability. However, additional production lines are being commissioned progressively during Q3 FY27, with the company targeting nearly 100 per cent capacity utilisation by the end of the quarter.
Vipul Shah, Chairman and Managing Director, Vipul Organics, said the company achieved record quarterly revenue through strategic optimisation and product diversification. He expressed confidence that increasing utilisation at the Sayakha facility would support the normalisation of profit margins.
Meanwhile, the company’s membrane division remains on schedule to begin trial production for its expanded capacity during Q4 FY27.
Vipul Organics continues to invest in research and development while strengthening its senior leadership team to support future growth. The company expects higher production capacity, operational efficiencies and improving industry conditions to strengthen its position in the speciality chemicals sector.
